Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

CAS No. :	789-61-7
Formula :	C₁₀H₁₃N₅O₃S
M.W :	283.31
SMILES Code :	S=C1NC(N)=NC2=C1N=CN2[C@@H]3O[C@H](CO)[C@@H](O)C3
Synonyms :	6-thio-dG; β-TGdR; Beta-TGdR
MDL No. :	MFCD00672275
InChI Key :	SCVJRXQHFJXZFZ-KVQBGUIXSA-N
Pubchem ID :	3000603

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P280-P301+P312-P302+P352-P305+P351+P338

MC38 cells	0.5 μM	13 days	Evaluate the effect of 6-thio-dG on colony formation of MC38 cells	PMC7494563
H1693 NSCLC cells	10 μM	4-7 days	Overexpression of SLC43A3 in H1693 cells increased sensitivity to 6-thio-dG.	PMC7056593
HCT116 cells	0.73 μM (IC50)	5 days	Determine the IC50 of 6-thio-dG in HCT116 cells	PMC7494563
MC38 cells	370 nM	5 days	Determine the IC50 of 6-thio-dG in MC38 cells	PMC7494563
H1299 parental and resistant cells	1, 3, 10 μM	1 week	Tested sensitivity in paclitaxel/carboplatin-resistant cells, both remained sensitive to 6-thio-dG	PMC6037876
HCEC1 human colonic epithelial cells	0.5–10 µM	1 week	To evaluate the effect of 6-thio-dG on normal cells, results showed that HCEC1 cells were largely resistant to 6-thio-dG.	PMC4293221
BJ human fibroblasts	0.5–10 µM	1 week	To evaluate the effect of 6-thio-dG on normal cells, results showed that BJ fibroblasts were largely resistant to 6-thio-dG.	PMC4293221
A549 lung cancer cells	0.5–10 µM	1 week	To evaluate the effect of 6-thio-dG on cell growth, results showed that 6-thio-dG caused rapid cell death in the majority of A549 cells.	PMC4293221
HCT116 colon cancer cells	0.5–10 µM	1 week	To evaluate the effect of 6-thio-dG on cell growth, results showed that 6-thio-dG caused rapid cell death in the majority of HCT116 cells.	PMC4293221
KLN205 mouse lung cancer cells	125, 250, 500 nM	11-13 days	Verified sensitivity to 6-thio-dG in mouse lung cancer cells	PMC6037876
Neurosphere-cultured glioma cell lines	5 μM	12 days	To evaluate the therapeutic efficacy of THIO in neurosphere-cultured glioma cell lines, results showed that THIO inhibited neurosphere growth by inducing apoptotic cell death.	PMC8678347
H2087 NSCLC cells	1 μM	3 days	Verified rapid effect on cell growth, no telomerase inhibition but significant impact on cell viability	PMC6037876
Non-small cell lung cancer (NSCLC) cell lines	1.55 μM (IC50)	4 days	To evaluate the sensitivity of NSCLC cell lines to 6-thio-dG, finding 73/77 cell lines were sensitive and 4/77 were resistant.	PMC7056593
TMZ-resistant glioma cell lines	5 μM	4 days	To evaluate the therapeutic efficacy of THIO in TMZ-resistant glioma cell lines, results showed that THIO as a monotherapy was effective in TMZ-resistant cell lines.	PMC8678347
Human and mouse glioma cell lines	0.01 μM to 100 μM	4 days	To evaluate the therapeutic efficacy of THIO in glioma cell lines, results showed that THIO was effective in the majority of glioma cell lines with no obvious toxicity against normal astrocytes.	PMC8678347
HCC4017 NSCLC cells	10 μM	4-7 days	Knockdown of SLC43A3 by siRNA resulted in resistance to 6-thio-dG in HCC4017 cells.	PMC7056593
Non-transformed melanocytes and fibroblasts	1 µM	7 days	To evaluate the effect of 6-thio-dG on non-transformed cells, results showed no significant effect.	PMC6062502
BRAF-V600E/NRAS-mutant cells derived from melanoma patients resistant to BRAF/MEK inhibitors	1 µM	7 days	To evaluate the effect of 6-thio-dG on the viability of BRAF/MEK inhibitor-resistant melanoma cells, results showed impaired cell viability.	PMC6062502
NRAS-mutant melanoma cells	1 µM	7 days	To evaluate the effect of 6-thio-dG on the viability of NRAS-mutant melanoma cells, results showed impaired cell viability.	PMC6062502
H2087 NSCLC cells	3 μM	9-18 days	Established acquired resistance model in H2087 cells, finding downregulation of SLC43A3 in resistant clones.	PMC7056593
SH-SY5Y	2.65 µM (GI50)	96 hours	To evaluate the synergistic anti-tumor effects of 6-thio-dG in combination with etoposide, doxorubicin, or ceritinib in neuroblastoma cell lines. Results showed robust synergistic effects for combinations with etoposide or doxorubicin, but weaker effects with ceritinib.	PMC9579108
BE(2)-C	2.65 µM (GI50)	96 hours	To evaluate the synergistic anti-tumor effects of 6-thio-dG in combination with etoposide, doxorubicin, or ceritinib in neuroblastoma cell lines. Results showed robust synergistic effects for combinations with etoposide or doxorubicin, but weaker effects with ceritinib.	PMC9579108
CLB-GA	2.65 µM (GI50)	96 hours	To evaluate the synergistic anti-tumor effects of 6-thio-dG in combination with etoposide, doxorubicin, or ceritinib in neuroblastoma cell lines. Results showed robust synergistic effects for combinations with etoposide or doxorubicin, but weaker effects with ceritinib.	PMC9579108
Human bronchial epithelial basal progenitor cells (HBECs)	3 μM	every 3 days for 3 passages	Inhibited colony growth, indicating toxicity of 6-thio-dG to HBECs with short telomeres	PMC6956733

Mice	HDM-induced allergic airway inflammation model	Intraperitoneal injection	5 mg/kg	Daily for one week (D21-D27)	Induction of telomere dysfunction to attenuate allergic response upon HDM exposure. Results showed that 6-thio-dG treated mice exhibited attenuated eosinophil counts, reduced serum IgE and IL13 levels, and decreased airway hyperresponsiveness (AHR) following HDM exposure.	PMC10803750
Nude mice	Xenograft model of H2087 sensitive and acquired resistant clones	Intraperitoneal injection	3 mg/kg	Five times a week for two weeks	To validate the response of H2087 sensitive and acquired resistant clones to 6-thio-dG, finding downregulation of SLC43A3 in resistant clones.	PMC7056593
Mice	MC38 tumor model	Intraperitoneal injection	3 mg/kg	Once daily for 3 days	Evaluate the anti-tumor effect of 6-thio-dG in immunocompetent Mice models	PMC7494563
Athymic nude mice	Subcutaneous xenograft model	Intraperitoneal injection	2.5 mg/kg	Three times per week for 28 days	To evaluate the anti-tumor effects of 6-thio-dG in combination with etoposide in neuroblastoma xenograft models. Results showed significant tumor growth inhibition and improved survival in CLB-GA and SH-SY5Y models, but not in BE(2)-C model.	PMC9579108
Athymic mice (nu/nu genotype, Balb/c background)	Glioma xenograft model	Intraperitoneal injection	3 mg/kg	Every other day for a total of 10 treatments	To evaluate the therapeutic efficacy of THIO in glioma xenograft models, results showed that THIO significantly delayed the growth of U87MG tumors but had no significant effect on U251MG tumors.	PMC8678347
Mice	NRAS-mutant melanoma xenograft model	Intraperitoneal injection	2.5 mg/kg	Once daily for 14 days	To evaluate the effect of 6-thio-dG on tumor growth in NRAS-mutant melanoma xenograft model, results showed slowed tumor growth.	PMC6062502
C57BL/6 mice	HDM-induced allergic airway inflammation model	Intraperitoneal injection	5 mg/kg	Daily for one week (D21-D27)	Induction of telomere dysfunction to attenuate allergic response upon HDM exposure. Results showed that 6-thio-dG treated mice exhibited attenuated eosinophil counts, reduced serum IgE and IL13 levels, and decreased airway hyperresponsiveness (AHR) following HDM exposure.	PMC8135011
Nude rats	Orthotopic oligodendroglioma model	Intraperitoneal injection	50 mg/kg	Daily for 7 days, then 4 times per week until tumors were no longer visible on MRI	To evaluate the therapeutic effect of 6-thio-dG on orthotopic oligodendrogliomas, results showed that 6-thio-dG significantly reduced 6-PG production at an early timepoint and significantly decreased tumor volume by day 14.	PMC10433788

{[proInfo.proName]}

CAS No.: 789-61-7

{[proInfo.proName]}

CAS No.: 789-61-7

Alternative Products

Product Details of 6-Thio-2'-Deoxyguanosine

Safety of 6-Thio-2'-Deoxyguanosine

Related Pathways of 6-Thio-2'-Deoxyguanosine

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	3.53mL 0.71mL 0.35mL	17.65mL 3.53mL 1.76mL	35.30mL 7.06mL 3.53mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed